Skip to main content

Table 9 Prognostic factors predicting severe acute toxicities

From: Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study

 

OR(95% CI)

P value

Acute toxicities

 Cetuximab (yes vs. no)

3.011

(1.533–5.915)

0.001

 RT technique (IMRT vs. 2D–RT)

8.326

(2.688–25.788)

<0.001

Late toxicities

 Age

0.917

(0.863–0.975)

0.006

 RT technique (IMRT vs. 2D–RT)

0.367

(0.133–1.016)

0.054

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us